L-Asparaginase in the treatment of refractory and relapsed extranodal NK/ T-cell lymphoma, nasal type

Annals of Hematology

Volumn 88, Issue 7, 2009, Pages 647-652

  Yong, Weiben ^a   Zheng, Wen ^a   Zhu, Jun ^a   Zhang, Yuntao ^a   Wang, Xiaopei ^a   Xie, Yan ^a   Lin, Ningjing ^a   Xu, Bo ^a   Lu, Aiping ^a   Li, Jiyou ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Chemotherapy; Extranodal NK T cell lymphoma; L Asparaginase; Prognostic factor; Radiotherapy

Indexed keywords

AMINOTRANSFERASE; ASPARAGINASE; BILIRUBIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; NITROGEN; PREDNISONE; UREA; VINCRISTINE; VINCRISTINE SULFATE;

ADULT; ALLERGIC REACTION; ARTICLE; BONE MARROW SUPPRESSION; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG EFFICACY; DRUG ERUPTION; DRUG FATALITY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; HYPOALBUMINEMIA; LEUKOPENIA; LIVER DYSFUNCTION; MALE; MULTIPLE CYCLE TREATMENT; NK T CELL LYMPHOMA; NOSE CANCER; OVERALL SURVIVAL; PANCREATITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALVAGE THERAPY; SIDE EFFECT; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; UREA NITROGEN BLOOD LEVEL;

ANTINEOPLASTIC AGENTS; ASPARAGINASE; COMBINED MODALITY THERAPY; DRUG EVALUATION; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; HYPERGLYCEMIA; LIVER DISEASES; LYMPHOMA, EXTRANODAL NK-T-CELL; MALE; MIDDLE AGED; NOSE NEOPLASMS; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS;

EID: 67349174996     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-008-0669-3     Document Type: Article

References (25)

1. Chan JK, Jaffe E, Ralfkiaer E (2001) Extranodal NK/T cell lymphoma, nasal type. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) Tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 204-207
2. Jaffe ES, Chan JKC, Su IJ et al (1996) Report of the workshop on nasal and related extranodal angiocentric T/nature killer cell lymphomas definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 20:103-111
3. Oshimi K (2003) Leukemia and lymphoma of natural killer lineage cells. Int J Hematol 78:18-23. doi: 10.1007/BF02983235
4. Au WY, Ma SY, Chim CS et al (2005) Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: A single center experience of 10 years. Ann Oncol 16:206-214. doi: 10.1093/annonc/mdi037
5. Lee J, Suh C, Park YH et al (2006) Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study. J Clin Oncol 24:612-618. doi: 10.1200/JCO.2005.04.1384
6. Tao Q, Ho FCS, Loke SL et al (1995) Epstein-Barr virus is localized in the tumor cells of nasal lymphoma of NK, T or B cell type. Int J Cancer 60:315-320. doi: 10.1002/ijc.2910600306
7. Kwong YL (2005) Nature killer-cell malignancies: Diagnosis and treatment. Leukemia 19:2186-2194. doi: 10.1038/sj.leu.2403955
8. Li CC, Tien HF, Tang JL et al (2004) Treatment outcomes and pattern of failure in 77 patients with sinonasal natural killer/T-cell or T-cell lymphoma. Cancer 100:366-375. doi: 10.1002/cncr.11908
9. Lee J, Park YH, Kim WS et al (2005) Extranodal nasal type NK/T-cell lymphoma: Elucidating clinical prognostic factors for risk-based stratification of therapy. Eur J Cancer 41:1402-1408. doi: 10.1016/ j.ejca.2005.03.010
10. 3 expression in lymphomas when studied on frozen and paraffin sections. Hum Pathol 26:1139-1143. doi: 10.1016/0046-8177(95)90277-5
11. Chan JK, Tsang WY, Ng CS (1996) Clarification of CD3 immunoreactivity in nasal T/natural killer cell lymphomas: The neoplastic cells are often CD3 epsilon+. Blood 87:839-841
12. Bunn PA Jr, Lamberg SI et al (1979) Report of the committee of staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep 63:702-728
13. Miller AB, Hoogstraten B, Staquet M et al (1981) Reporting results of cancer treatment. Cancer 47:207-214. doi: 10.1002/ 1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6
14. Kim GE, Lee SW, Chang SK et al (2001) Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck. Radiother Oncol 61:261-269. doi: 10.1016/S0167-8140(01)00428-5
15. Li JX, Yao B, Jin J et al (2006) Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma. J Clin Oncol 24:181-189. doi: 10.1200/JCO.2005.03.2573
16. Cheung MM, Chan JK, Lau WH et al (2002) Early stage nasal NK/T-cell lymphoma: Clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 54:182-190. doi: 10.1016/S0360-3016(02)02916-4
17. Isobe K, Uno T, Tamaru JI et al (2006) Extranodal natural killer/T-cell lymphoma, nasal type the significance of radiotherapeutic parameters. Cancer 106:609-615. doi: 10.1002/cncr.21656
18. Koom WS, Chung EJ, Yang WI et al (2004) Angiocentric T-cell and NK/ T-cell lymphomas: Radiotherapeutic viewpoints. Int J Radiat Oncol Biol Phys 59:1127-1137. doi: 10.1016/j.ijrobp.2003.12.006
19. Cheung MMC, Chan JKC, Lau WH et al (1998) Primary non-Hodgkin's lymphoma of the nose and nasopharynx: Clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 16:70-77
20. Yong W, Zheng W, Zhu J et al (2006) Midline NK/T-cell lymphoma nasal-type: Treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors. Hematol Oncol 24:28-32. doi: 10.1002/ hon.765
21. Chaudhary PM, Mechetner EB, Roninson IB (1992) Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood 80:2735-2739
22. Yamaguchi M, Kita K, Miwa H et al (1995) Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer 76:2351-2356. doi: 10.1002/ 1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1
23. Yong W, Zheng W, Zhu J et al (2003) L-asparaginase-based regimen in the treatment of refractory midline T/NK-cell lymphoma. Int J Hematol 78:163-167. doi: 10.1007/BF02983387
24. Nagafuji K, Fujisaki t, Arima F et al (2001) L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation. Int J Hematol 74:447-450. doi: 10.1007/BF02982090
25. Takahashi N, Miura I, Chubachi A et al (2001) A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma. Int J Hematol 74:303-308. doi: 10.1007/BF02982065